Purification, Properties and Function of N-Hydroxyarylamine O- Acetyltransferase

  • Ryuichi Kato
  • Kazuki Saito
  • Atsuko Shinohara
  • Tetsuya Kamataki
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 197)


Among numbers of environmental or chemical carcinogens, those which are contained in daily foods can be regarded as the most causative factors of cancers. Thus, the discovery of mutagens/carcinogens in the pyrolysis products of amino acids and proteins was a striking matter. Some of the promutagens isolated so far induce remarkable numbers of revertants when incubated with Salmonella typhimurium TA98 bacterial cells in the presence of 9,000 xg supernatant fraction of liver homogenates of PCB-treated rats with cofactors. The specific mutagenicity of some of promutagens represented as the number of revertants per μg of a promutagen, reaches to levels 1000 times as high as benzo(a)pyrene.


Covalent Binding Acyl Donor Ammonium Sulfate Fractionation Liver Cytosol Hamster Liver 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Y. Yamazoe, M. Shimada, T. Kamataki, and R. Kato, Microsomal activation of 2-amino-3-methylimidazo[4,5-f] quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate, Cancer Res., 43: 5768 (1983).PubMedGoogle Scholar
  2. 2.
    R. Kato, T. Kamataki, and Y. Yamazoe, N-Hydroxylation of carcinogenic and mutagenic aromatic amines, Environ. Health Prerspec., 49: 21 (1983).CrossRefGoogle Scholar
  3. 3.
    T. Kamataki, K. Maeda, Y. Yamazoe, N. Matsuda, K. Ishii, and R. Kato, A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats, Molec. Pharmacol., 24: 146 (1983).Google Scholar
  4. 4.
    R. Kato, T. Kamataki, and Y. Yamazoe, High spin cytochrome P-448 with high activity for mutagenic activation of aromatic amines, in “Developments in the Science and Practice of Toxicology”, A. W. Hayes, R. C. Schnell, T. S. Miya, ed., Elsevier Science Publishers B.V., Amsterdam (1983).Google Scholar
  5. 5.
    S. Mita, K. Ishii, Y. Yamazoe, T. Kamataki, R. Kato, and T. Sugimura, Evidence for the involvement of N-hydroxylation of 3-amino-l-methyl-5H-pyrido[4,3-b]indole by cytochrome P-450 in the covalent binding to DNA, Cancer Res., 41: 3610, (1981).PubMedGoogle Scholar
  6. 6.
    Y. Yamazoe, M. Shimada, T. Kamataki, and R. Kato, Covalent binding of N-hydroxy-Trp-P-2 to DNA by cytosolic proline-dependent system, Biochem. Biophys. Res. Commun., 107: 165 (1982).PubMedCrossRefGoogle Scholar
  7. 7.
    Y. Yamazoe, M. Shimada, A. Shinohara, K. Saito, T. Kamataki, and R. Kato, Catalysis of the covalent binding of 3-hydroxyamino-l-methyl-5H-pyrido[4,3-b]indole to DNA by a L-proline-adenosine triphosphate-dependent enzyme in rat hepatic cytosol, Cancer Res., 45: 2495 (1985).PubMedGoogle Scholar
  8. 8.
    E. C. McCoy, G. D. McCoy, and H. S. Rosenkranz, Esterification of arylhydroxylamine: Evidence for a specific gene product in mutagenesis, Biochem. Biophys. Res. Commun., 108: 1362 (1982).PubMedCrossRefGoogle Scholar
  9. 9.
    K. Saito, Y. Yamazoe, T. Kamataki, and R. Kato, Mechanism of activation of proximate mutagens in Ames’ tester strains: The acetylCoA dependent enzyme in Salmonella typhimurium TA98 deficient in TA98/1,8-DNP6 catalyzes DNA-binding as the cause of mutagenicity, Biochem. Biophys. Res. Commun., 116: 141 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    K. Saito, A. Shinohara, T. Kamataki, and R. Kato, Metabolic activation of mutagenic N-hydroxyarylamines by 0-acetyltransferase in Salmonella typhimurium TA98, Arch. Biochem. Biophys., 239: 286 (1985).PubMedCrossRefGoogle Scholar
  11. 11.
    A. Shinohara, K. Saito, Y. Yamazoe, T. Kamataki, and R. Kato, DNA binding of N-hydroxy-Trp-p-2 and N-hydroxy-Glu-P-1 by acetyl-CoA dependent enzyme in mammalian liver cytosol, Carcinogenesis, 6: 305 (1985).PubMedCrossRefGoogle Scholar
  12. 12.
    A. Shinohara, K. Saito, T. Kamataki, and R. Kato, Acetyl coenzyme A-dependent activation of carcinogenic N-hydroxyarylamines: Mechanism of activation, species difference, tissue distribution and acetyl donor, Cancer Res., Submitted for purblication (1985).Google Scholar
  13. 13.
    T. J. Flammang, and F. F. Kadlubar, Acetyl coenzyme A-dependent metabolic activation of carcinogenic N-hydroxyarylamines, Proc. Am. Assoc. Cancer Res., 25: 120 (1984).Google Scholar
  14. 14.
    T. J. Flammang, J. G. Westra, F. F. Kadlubar, and F. A. Beland, DNA adducts formed from the probable proximate carcinogen, N-hydroxy-3,2’dimethyl-4-aminobiphenyl, by acid catalysis or S-acetyl coenzyme A-dependent enzymatic esterification, Carcinogenesis, 6: 251 (1985).PubMedCrossRefGoogle Scholar
  15. 15.
    W. T. Allaben, and C. M. King, The purification of rat liver arylhydroxamic acid N,O-acyltransferase, J. Biol. Chem., 259: 12128 (1984).PubMedGoogle Scholar
  16. 16.
    I. B. Glowinski, and W. W. Weber, Evidence that arylhydroxamic acid N,O-acyltransferase and the genetically polymorphic Nacetyltransferase are properties of the same enzyme in rabbit liver, J. Biol. Chem., 255: 7883 (1980).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Ryuichi Kato
    • 1
  • Kazuki Saito
    • 1
  • Atsuko Shinohara
    • 1
  • Tetsuya Kamataki
    • 1
  1. 1.Department of PharmacologySchool of Medicine, Keio UniversityTokyo, 160Japan

Personalised recommendations